This is why health giant Johnson & Johnson is my undisputed favorite in the pharmaceutical sector!

When it comes to top-class investments in the healthcare sector, there’s currently no way around Johnson & Johnson (i)(JNJ) for me. The company impressively demonstrates how to combine sheer size with rapid innovation. The foundation of this success is built on two extremely strong pillars: Innovative Medicine, which is the pharmaceuticals division, and Medical Technology. Recently, both areas have shown impressive numbers. The pharmaceuticals division surpassed the $60 billion revenue mark for the first time in 2025, growing by nearly 8%...